Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
Ann Surg Oncol. 2013 Aug;20(8):2526-33. doi: 10.1245/s10434-013-2940-7. Epub 2013 Mar 16.
To determine the prognostic factors that predict recurrence of hepatocellular carcinoma (HCC) exceeding the University of California at San Francisco (UCSF) criteria after primary resection.
HCC patients who underwent curative liver resections between 2001 and 2007 and who were within the UCSF criteria (n = 716) were examined. Independent prognostic factors were examined by the Cox proportional hazard model.
A total of 285 patients (39.8 %) developed recurrences. Of the patients who developed recurrences, 180 had HCC still within the UCSF criteria (63.2 %), and 105 developed HCC beyond this criteria (36.8 %). Among the population with primary transplantable HCC, patients with larger primary tumor sizes, serum α-fetoprotein (AFP) levels over 400 ng/mL, satellite nodules, vascular invasion, or undifferentiated HCC had a risk of untransplantable recurrence, as shown by univariate analysis. In multivariate analysis, undifferentiated HCC and vascular invasion were identified as the significant predictors with adjusted hazard ratios of 9.25 [95 % confidence interval (CI) 2.13-40.21] and 2.19 (95 % CI 1.34-3.58), respectively. When only preoperative factors were considered in multivariate analysis, primary tumor size and serum AFP levels over 400 ng/mL were identified as significant predictors with adjusted hazard ratios of 1.24 (95 % CI 1.07-1.45) and 1.72 (95 % CI 1.05-2.82), respectively.
For primary HCC patients within the UCSF criteria, larger tumor sizes and AFP levels over 400 ng/mL were associated with postresection recurrence of HCC exceeding the UCSF criteria. Because these are clearly markers for aggressive tumor biology, whether early primary transplant will alter the aggressive tumor behaviors warrant further investigation.
确定预测加利福尼亚大学旧金山分校(UCSF)标准内原发性切除术后肝细胞癌(HCC)复发的预后因素。
检查了 2001 年至 2007 年间接受根治性肝切除术且符合 UCSF 标准的 HCC 患者(n=716)。使用 Cox 比例风险模型检查独立的预后因素。
共有 285 例患者(39.8%)发生了复发。在发生复发的患者中,180 例 HCC 仍在 UCSF 标准内(63.2%),105 例 HCC 超出此标准(36.8%)。在原发性可移植 HCC 人群中,原发性肿瘤较大、血清α-胎蛋白(AFP)水平超过 400ng/mL、卫星结节、血管侵犯或未分化 HCC 的患者,通过单因素分析显示出不可移植性复发的风险。多因素分析显示,未分化 HCC 和血管侵犯是有意义的预测因子,调整后的危险比分别为 9.25(95%可信区间:2.13-40.21)和 2.19(95%可信区间:1.34-3.58)。当仅在多因素分析中考虑术前因素时,原发性肿瘤大小和血清 AFP 水平超过 400ng/mL 被确定为有意义的预测因子,调整后的危险比分别为 1.24(95%可信区间:1.07-1.45)和 1.72(95%可信区间:1.05-2.82)。
对于符合 UCSF 标准的原发性 HCC 患者,较大的肿瘤大小和 AFP 水平超过 400ng/mL 与 UCSF 标准内 HCC 切除术后复发相关。因为这些显然是侵袭性肿瘤生物学的标志物,早期进行原发性移植是否会改变侵袭性肿瘤行为值得进一步研究。